project	sample	experiment	run	read_count_as_reported_by_sra	reads_downloaded	proportion_of_reads_reported_by_sra_downloaded	paired_end	sra_misreported_paired_end	mapped_read_count	auc	sharq_beta_tissue	sharq_beta_cell_type	biosample_submission_date	biosample_publication_date	biosample_update_date	avg_read_length	geo_accession	bigwig_file	title	characteristics
SRP032165	SRS494266	SRX368226	SRR1017150	15460643	15460643	1	FALSE	FALSE	14304591	553774417	brain	mb	2013-10-25T19:10:46.663	2013-11-13T02:23:55.553	2014-03-07T16:07:42.669	45	GSM1250453	SRR1017150.bw	ALS20	c("tissue: Fibroblast", "gender: Male", "age: 54 Years", "genotype: Unknown Mutation", "diagnosis: Sporadic ALS", "disease onset: Arm", "disease course: 10 months at time of biopsy", "drug treatment: No ASO Treatment - Cells were exposed to cytofectin transfection reagent for four hours, but were not transfected with an ASO")
SRP032165	SRS494267	SRX368225	SRR1017149	16362053	16362053	1	FALSE	FALSE	15306981	594398532	brain	mb	2013-10-25T19:10:48.950	2013-11-13T02:23:54.213	2014-03-07T16:07:42.707	45	GSM1250452	SRR1017149.bw	ALS14	c("tissue: Fibroblast", "gender: Male", "age: 46 Years", "genotype: Unknown Mutation", "diagnosis: Sporadic ALS", "disease onset: Bulbar", "disease course: 6 years at time of biopsy", "drug treatment: No ASO Treatment - Cells were exposed to cytofectin transfection reagent for four hours, but were not transfected with an ASO")
SRP032165	SRS494268	SRX368228	SRR1017152	17001078	17001078	1	FALSE	FALSE	15801667	611947038	brain	mb	2013-10-25T19:10:57.227	2013-11-13T02:23:58.047	2014-03-07T16:07:42.886	45	GSM1250455	SRR1017152.bw	ALS2	c("tissue: Fibroblast", "gender: Male", "age: 54 Years", "genotype: Unknown Mutation", "diagnosis: Sporadic ALS", "disease onset: Bulbar", "disease course: 2.5 years at time of biopsy", "drug treatment: No ASO Treatment - Cells were exposed to cytofectin transfection reagent for four hours, but were not transfected with an ASO")
SRP032165	SRS494269	SRX368227	SRR1017151	13903116	13903116	1	FALSE	FALSE	12902012	500039156	brain	mb	2013-10-25T19:10:50.927	2013-11-13T02:23:56.767	2014-03-07T16:07:42.744	45	GSM1250454	SRR1017151.bw	ALS25	c("tissue: Fibroblast", "gender: Male", "age: 46 Years", "genotype: Unknown Mutation", "diagnosis: Sporadic ALS", "disease onset: Bulbar", "disease course: 2 years at time of biopsy", "drug treatment: No ASO Treatment - Cells were exposed to cytofectin transfection reagent for four hours, but were not transfected with an ASO")
SRP032165	SRS494270	SRX368229	SRR1017153	18698729	18698729	1	FALSE	FALSE	17098805	657412393	brain	mb	2013-10-25T19:10:52.970	2013-11-13T02:23:59.530	2014-03-07T16:07:42.788	45	GSM1250456	SRR1017153.bw	C9-1-Ctrl	c("tissue: Fibroblast", "gender: Male", "age: 52 Years", "genotype: C9orf72 Intron 1 Hexanucleotide Expansion", "diagnosis: Familial ALS and Dementia", "disease onset: Bulbar", "disease course: 4 years at time of biopsy", "drug treatment: No ASO Treatment - Cells were exposed to cytofectin transfection reagent for four hours, but were not transfected with an ASO")
SRP032165	SRS494271	SRX368230	SRR1017154	23092404	23092404	1	FALSE	FALSE	21510009	836739276	brain	mb	2013-10-25T19:10:55.077	2013-11-13T02:24:00.997	2014-03-07T16:07:42.846	45	GSM1250457	SRR1017154.bw	C9-1-Mock	c("tissue: Fibroblast", "gender: Male", "age: 52 Years", "genotype: C9orf72 Intron 1 Hexanucleotide Expansion", "diagnosis: Familial ALS and Dementia", "disease onset: Bulbar", "disease course: 4 years at time of biopsy", "drug treatment: Transfection Control - Cells were treated with a control ASO which does not have any human genomic target.")
SRP032165	SRS494272	SRX368232	SRR1017156	17524371	17524371	1	FALSE	FALSE	16454409	639569271	brain	mb	2013-10-25T19:11:02.657	2013-11-13T02:24:03.630	2014-03-07T16:07:43.010	45	GSM1250459	SRR1017156.bw	C9-2-Ctrl	c("tissue: Fibroblast", "gender: Male", "age: 52 Years", "genotype: C9orf72 Intron 1 Hexanucleotide Expansion", "diagnosis: Sporadic ALS (C9orf72 expansion)", "disease onset: Distal UE", "disease course: 1 year at time of biopsy", "drug treatment: No ASO Treatment - Cells were exposed to cytofectin transfection reagent for four hours, but were not transfected with an ASO")
SRP032165	SRS494273	SRX368231	SRR1017155	17900509	17900509	1	FALSE	FALSE	16609258	648212205	brain	mb	2013-10-25T19:10:59.290	2013-11-13T02:24:02.513	2014-03-07T16:07:42.926	45	GSM1250458	SRR1017155.bw	C9-1-Tx	c("tissue: Fibroblast", "gender: Male", "age: 52 Years", "genotype: C9orf72 Intron 1 Hexanucleotide Expansion", "diagnosis: Familial ALS and Dementia", "disease onset: Bulbar", "disease course: 4 years at time of biopsy", "drug treatment: ASO Treatment - Cells were transfected with a nuclear RNase-H dependent antisense oligonucleotide targeting Exon 2 of Hs C9orf72. This ASO has been shown in previous work to efficiently knockdown all known isoforms of C9orf72.")
SRP032165	SRS494274	SRX368233	SRR1017157	22101736	22101736	1	FALSE	FALSE	20727861	805839502	brain	mb	2013-10-25T19:11:01.240	2013-11-13T02:24:04.937	2014-03-07T16:07:42.969	45	GSM1250460	SRR1017157.bw	C9-2-Mock	c("tissue: Fibroblast", "gender: Male", "age: 52 Years", "genotype: C9orf72 Intron 1 Hexanucleotide Expansion", "diagnosis: Sporadic ALS (C9orf72 expansion)", "disease onset: Distal UE", "disease course: 1 year at time of biopsy", "drug treatment: Transfection Control - Cells were treated with a control ASO which does not have any human genomic target.")
SRP032165	SRS494275	SRX368234	SRR1017158	24009506	24009506	1	FALSE	FALSE	22094618	851998655	brain	mb	2013-10-25T19:11:03.653	2013-11-13T02:24:06.623	2014-03-07T16:07:43.051	45	GSM1250461	SRR1017158.bw	C9-2-Tx	c("tissue: Fibroblast", "gender: Male", "age: 52 Years", "genotype: C9orf72 Intron 1 Hexanucleotide Expansion", "diagnosis: Sporadic ALS (C9orf72 expansion)", "disease onset: Distal UE", "disease course: 1 year at time of biopsy", "drug treatment: ASO Treatment - Cells were transfected with a nuclear RNase-H dependent antisense oligonucleotide targeting Exon 2 of Hs C9orf72. This ASO has been shown in previous work to efficiently knockdown all known isoforms of C9orf72.")
SRP032165	SRS494276	SRX368235	SRR1017159	27436986	27436986	1	FALSE	FALSE	25533583	986212782	brain	mb	2013-10-25T19:11:07.333	2013-11-13T02:24:08.367	2014-03-07T16:07:43.128	45	GSM1250462	SRR1017159.bw	C9-3-Ctrl	c("tissue: Fibroblast", "gender: Male", "age: 55 Years", "genotype: C9orf72 Intron 1 Hexanucleotide Expansion", "diagnosis: Familial ALS", "disease onset: Unknown", "disease course: 14 years at time of biopsy", "drug treatment: No ASO Treatment - Cells were exposed to cytofectin transfection reagent for four hours, but were not transfected with an ASO")
SRP032165	SRS494277	SRX368236	SRR1017160	15871571	15871571	1	FALSE	FALSE	14788596	572804815	brain	mb	2013-10-25T19:11:11.283	2013-11-13T02:24:12.337	2014-03-07T16:07:43.213	45	GSM1250463	SRR1017160.bw	C9-3-Mock	c("tissue: Fibroblast", "gender: Male", "age: 55 Years", "genotype: C9orf72 Intron 1 Hexanucleotide Expansion", "diagnosis: Familial ALS", "disease onset: Unknown", "disease course: 14 years at time of biopsy", "drug treatment: Transfection Control - Cells were treated with a control ASO which does not have any human genomic target.")
SRP032165	SRS494278	SRX368237	SRR1017161	18236578	18236578	1	FALSE	FALSE	17043788	658108955	brain	mb	2013-10-25T19:11:05.257	2013-11-13T02:25:18.490	2014-03-07T16:07:43.091	45	GSM1250464	SRR1017161.bw	C9-3-Tx	c("tissue: Fibroblast", "gender: Male", "age: 55 Years", "genotype: C9orf72 Intron 1 Hexanucleotide Expansion", "diagnosis: Familial ALS", "disease onset: Unknown", "disease course: 14 years at time of biopsy", "drug treatment: ASO Treatment - Cells were transfected with a nuclear RNase-H dependent antisense oligonucleotide targeting Exon 2 of Hs C9orf72. This ASO has been shown in previous work to efficiently knockdown all known isoforms of C9orf72.")
SRP032165	SRS494279	SRX368238	SRR1017162	19745862	19745862	1	FALSE	FALSE	18413904	715148404	brain	mb	2013-10-25T19:11:09.280	2013-11-13T02:25:19.870	2014-03-07T16:07:43.174	45	GSM1250465	SRR1017162.bw	C9-4-Ctrl	c("tissue: Fibroblast", "gender: Male", "age: 55 Years", "genotype: C9orf72 Intron 1 Hexanucleotide Expansion", "diagnosis: Familial ALS", "disease onset: Leg", "disease course: 2 years at time of biopsy", "drug treatment: No ASO Treatment - Cells were exposed to cytofectin transfection reagent for four hours, but were not transfected with an ASO")
SRP032165	SRS494280	SRX368239	SRR1017163	20022098	20022098	1	FALSE	FALSE	18670740	729214188	brain	mb	2013-10-25T19:11:19.137	2013-11-13T02:25:21.960	2014-03-07T16:07:43.352	45	GSM1250466	SRR1017163.bw	C9-4-Mock	c("tissue: Fibroblast", "gender: Male", "age: 55 Years", "genotype: C9orf72 Intron 1 Hexanucleotide Expansion", "diagnosis: Familial ALS", "disease onset: Leg", "disease course: 2 years at time of biopsy", "drug treatment: Transfection Control - Cells were treated with a control ASO which does not have any human genomic target.")
SRP032165	SRS494281	SRX368240	SRR1017164	19031451	19031451	1	FALSE	FALSE	17766442	690197779	brain	mb	2013-10-25T19:11:15.260	2013-11-13T02:25:23.543	2014-03-07T16:07:43.284	45	GSM1250467	SRR1017164.bw	C9-4-Tx	c("tissue: Fibroblast", "gender: Male", "age: 55 Years", "genotype: C9orf72 Intron 1 Hexanucleotide Expansion", "diagnosis: Familial ALS", "disease onset: Leg", "disease course: 2 years at time of biopsy", "drug treatment: ASO Treatment - Cells were transfected with a nuclear RNase-H dependent antisense oligonucleotide targeting Exon 2 of Hs C9orf72. This ASO has been shown in previous work to efficiently knockdown all known isoforms of C9orf72.")
SRP032165	SRS494282	SRX368241	SRR1017165	22057144	22057144	1	FALSE	FALSE	20657700	800928222	brain	mb	2013-10-25T19:11:13.250	2013-11-13T02:32:43.163	2014-03-07T16:07:43.247	45	GSM1250468	SRR1017165.bw	Kin1ALS17-Ctrl	c("tissue: Fibroblast", "gender: Female", "age: 52 Years", "genotype: No Known Relevant Mutations", "diagnosis: Non-Neurologic Control", "disease onset: N/A", "disease course: N/A", "drug treatment: No ASO Treatment - Cells were exposed to cytofectin transfection reagent for four hours, but were not transfected with an ASO")
SRP032165	SRS494283	SRX368242	SRR1017166	22005395	22005395	1	FALSE	FALSE	20128497	765792852	brain	mb	2013-10-25T19:10:26.527	2013-11-13T02:32:44.810	2014-03-07T16:07:42.258	45	GSM1250469	SRR1017166.bw	Kin1ALS17-Tx	c("tissue: Fibroblast", "gender: Female", "age: 52 Years", "genotype: No Known Relevant Mutations", "diagnosis: Non-Neurologic Control", "disease onset: N/A", "disease course: N/A", "drug treatment: ASO Treatment - Cells were transfected with a nuclear RNase-H dependent antisense oligonucleotide targeting Exon 2 of Hs C9orf72. This ASO has been shown in previous work to efficiently knockdown all known isoforms of C9orf72.")
SRP032165	SRS494284	SRX368243	SRR1017167	24091533	24091533	1	FALSE	FALSE	22054798	846867281	brain	mb	2013-10-25T19:10:20.640	2013-11-13T02:32:34.397	2014-03-07T16:07:42.136	45	GSM1250470	SRR1017167.bw	Kin1ALS6-Ctrl	c("tissue: Fibroblast", "gender: Female", "age: 83 Years", "genotype: No Known Relevant Mutations", "diagnosis: Non-Neurologic Control", "disease onset: N/A", "disease course: N/A", "drug treatment: No ASO Treatment - Cells were exposed to cytofectin transfection reagent for four hours, but were not transfected with an ASO")
SRP032165	SRS494285	SRX368244	SRR1017168	23608468	23608468	1	FALSE	FALSE	21813402	838704546	brain	mb	2013-10-25T19:10:24.637	2013-11-13T02:32:35.810	2014-03-07T16:07:42.220	45	GSM1250471	SRR1017168.bw	Kin1ALS6-Tx	c("tissue: Fibroblast", "gender: Female", "age: 83 Years", "genotype: No Known Relevant Mutations", "diagnosis: Non-Neurologic Control", "disease onset: N/A", "disease course: N/A", "drug treatment: ASO Treatment - Cells were transfected with a nuclear RNase-H dependent antisense oligonucleotide targeting Exon 2 of Hs C9orf72. This ASO has been shown in previous work to efficiently knockdown all known isoforms of C9orf72.")
SRP032165	SRS494286	SRX368245	SRR1017169	19256902	19256902	1	FALSE	FALSE	18098589	703478761	brain	mb	2013-10-25T19:10:22.657	2013-11-13T02:23:43.880	2014-03-07T16:07:42.183	45	GSM1250472	SRR1017169.bw	Kin2ALS6-Ctrl	c("tissue: Fibroblast", "gender: Male", "age: 56 Years", "genotype: No Known Relevant Mutations", "diagnosis: Non-Neurologic Control", "disease onset: N/A", "disease course: N/A", "drug treatment: No ASO Treatment - Cells were exposed to cytofectin transfection reagent for four hours, but were not transfected with an ASO")
SRP032165	SRS494287	SRX368247	SRR1017171	18850727	18850727	1	FALSE	FALSE	17581537	683328857	brain	mb	2013-10-25T19:11:21.323	2013-11-13T02:25:55.800	2014-03-07T16:07:43.385	45	GSM1250474	SRR1017171.bw	Kin4ALS6-Ctrl	c("tissue: Fibroblast", "gender: Male", "age: 55 Years", "genotype: No Known Relevant Mutations", "diagnosis: Non-Neurologic Control", "disease onset: N/A", "disease course: N/A", "drug treatment: No ASO Treatment - Cells were exposed to cytofectin transfection reagent for four hours, but were not transfected with an ASO")
SRP032165	SRS494288	SRX368246	SRR1017170	17727289	17727289	1	FALSE	FALSE	16579655	643647377	brain	mb	2013-10-25T19:11:17.210	2013-11-13T02:25:44.930	2014-03-07T16:07:43.320	45	GSM1250473	SRR1017170.bw	Kin2ALS6-Tx	c("tissue: Fibroblast", "gender: Male", "age: 56 Years", "genotype: No Known Relevant Mutations", "diagnosis: Non-Neurologic Control", "disease onset: N/A", "disease course: N/A", "drug treatment: ASO Treatment - Cells were transfected with a nuclear RNase-H dependent antisense oligonucleotide targeting Exon 2 of Hs C9orf72. This ASO has been shown in previous work to efficiently knockdown all known isoforms of C9orf72.")
SRP032165	SRS494289	SRX368248	SRR1017172	28162146	28162146	1	FALSE	FALSE	26231862	1021635216	brain	mb	2013-10-25T19:10:18.313	2013-11-13T02:32:41.500	2014-03-07T16:07:42.090	45	GSM1250475	SRR1017172.bw	Kin4ALS6-Tx	c("tissue: Fibroblast", "gender: Male", "age: 55 Years", "genotype: No Known Relevant Mutations", "diagnosis: Non-Neurologic Control", "disease onset: N/A", "disease course: N/A", "drug treatment: ASO Treatment - Cells were transfected with a nuclear RNase-H dependent antisense oligonucleotide targeting Exon 2 of Hs C9orf72. This ASO has been shown in previous work to efficiently knockdown all known isoforms of C9orf72.")